Triton Therapeutics, Inc. — Form D
Triton Therapeutics, Inc. of STAMFORD, CT, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-23. The offering totals $36.4M, of which $36.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-10-23
- Form: D
- Accession: 0002088152-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $36.4M
- Amount sold: $36.4M
- Investors: 4
- Date of first sale: 2025-10-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-561892
Issuer
- Name: Triton Therapeutics, Inc.
- CIK: 0002088152
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 700 FAIRFIELD AVENUE, SUITE 1, STAMFORD, CT, 06902
- Phone: 203-482-3123
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Paul Fonteyne | Director | New Haven, CT |
| Elena Grigoryeva | Director | Princeton, NJ |
| Annie Mitsak | Director | Boston, MA |
| Timothy Shannon | Director | Stamford, CT |
| Paul Fonteyne | Executive Officer | New Haven, CT |
More